Industry
Cali Pharmaceuticals LLC
Total Trials
6
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
Failure Rate
0.0%
0 terminated/withdrawn out of 6 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
Phase 3
3(50.0%)
Phase 2
3(50.0%)
6Total
Phase 3(3)
Phase 2(3)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (6)
Showing 6 of 6 trials
NCT05813847Phase 3Completed
Herniorrhaphy for Postoperative Pain
Role: lead
NCT05831449Phase 3Completed
CPL-01 in the Management of Postoperative Pain After Bunionectomy
Role: lead
NCT04182880Phase 2Completed
Evaluate the Safety and Pharmacokinetic Profile of CPL-01 in the Management of Acute Postoperative Pain
Role: lead
NCT07490496Phase 3Not Yet Recruiting
Phase 3 Bunionectomy Study
Role: lead
NCT05411861Phase 2Completed
Post-Operative Pain and Opioid Reduction Trial After Bunionectomy
Role: lead
NCT05080959Phase 2Completed
A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy
Role: lead
All 6 trials loaded